🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to investigate the efficacy and safety of PET regimen combi...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2017-03-01
Trial ID
NCT03273452
Treatments Being Tested
Undifferentiated connective tissue diseases (UCTD) are known to increase th...
Status
Unknown
Location
Renji Hospital
Start Date
2019-08-02
Trial ID
NCT03671174
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested
This phase II trial studies how well docetaxel or abiraterone acetate work ...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2019-02-08
Trial ID
NCT03827473
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
Primary objective of the study is to compare the efficacy of romidepsin whe...
Status
Completed
Location
ZNA Stuivenberg
Start Date
2013-01
Trial ID
NCT01796002
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2003-11
Trial ID
NCT00059839
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested